Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

171.24 UNCHANGED
Streaming Delayed Price Updated: 4:15 PM EST, Jan 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
News headline image
Weekly Update - Sunday, June 16 ↗
Today, I want to get right down to the technical analysis with some actionable plans. It should not come as a surprise to see the indices diverge even further than where they have been over the last... 
Via Talk Markets
News headline image
Thoughts For Thursday: Tech Still Leading ↗
The stock market continued to pull higher Wednesday with the biggest points gained in the Nasdaq Composite. Tech is still the big leader. 
Via Talk Markets
Topics Stocks
News headline image
Large Cap BIopharmaceuticals Overview ↗
As a defensive play healthcare is weighted at about 12% of the S&P 500. 
Via Talk Markets
Topics Stocks
News headline image
Pay No Attention To That Tran Behind The Curtain? ↗
For the sake of redundancy and in case you are living under a rock and just came out to read my Daily, Nvidia (NVDA) and its ginormous beat on revenues, gave the market new life. 
Via Talk Markets
News headline image
Why the Rest of 2024 Could Be Good for Investing in Biotech Stocks ↗
Investors have been ignoring biotech stocks for far too long. Here's why they could start to heat up in 2024. 
Via InvestorPlace
News headline image
Large Cap Biopharmaceuticals Performance ↗
The biotech sector remains a laggard YTD as can be seen by the IBB​​​​​​​. 
Via Talk Markets
News headline image
For Biotech Stocks To Move Higher, This Must Move Lower ↗
While biotechs have significantly lagged behind the broader market, there is reason to be optimistic once inflation-related volatility subsides. IBB and XBI present good vehicles for biotech exposure. 
Via Talk Markets
News headline image
Will the Biotech Sector Shift From Lagger to Leader?
The biotech sector has experienced a significant rally after bouncing off uptrend support and is now consolidating near major SMAs. 
Via MarketBeat
Topics ETFs
News headline image
Consumer Spending - Single Most Driving Force ↗
The choices we make as consumers collectively shape the economic landscape, and our spending patterns influence the well-being of our communities and the nation. 
Via Talk Markets
News headline image
Economic Modern Family-Tell Us a Story ↗
Taking a look at the markets and how to best prepare for the coming week. 
Via Talk Markets
News headline image
When Silver Looks Bad, It’s Been A Sign Of A Bottom ↗
Silver cleared $26 but for only 3 weeks. Then it gapped lower in early May 2023 and did not clear that level ($26) again for a year. 
Via Talk Markets
News headline image
April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market ↗
Performance in April 2024: Utilities lead, real estate lags. S&P 500, Nasdaq 100, Dow Jones Industrial Average, small-cap and large-cap indices all decline. 
Via Benzinga
Topics Stocks
News headline image
Can Semiconductors Pull Off Another Sustained Rally? ↗
With all the news flying around, we have found incredible confidence in our trading strategies by following the technical picture. 
Via Talk Markets
News headline image
Quick Look At The Economic Modern Family ↗
While I am extremely focused on commodities as outlined in Monday’s Daily, my viewpoint for most equities remains cautious to neutral. What might turn us to be more bullish? Let’s analyze. 
Via Talk Markets
News headline image
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead ↗
Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28. 
Via Talk Markets
News headline image
Massive Weekly Price Consolidation Will Show The Way ↗
Consolidation is one of our favorite chart patterns, especially when prices are consolidating at new highs or lows. The direction the price follows, up or down out of the consolidation can lead to... 
Via Talk Markets
News headline image
Rangebound Major Secor ETFs - What’s Next? ↗
Watching certain instruments for clues on the next moves, probably the best (equities) to watch is the major sector ETFs. 
Via Talk Markets
Topics ETFs
News headline image
Biotech Sector Nears Breakout: Will it Outperform in Q2?
The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gains 
Via MarketBeat
Topics ETFs
News headline image
5 Healthcare Stocks to Buy for 2024 ↗
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Healthcare And Biotech Stocks Review: Q1 2024 Performance ↗
We just had one of the best first quarters in recent market history since Q1 in 2019 when the market was up 13%. But changes in sector performance may be coming. The S&P 500 was up 10% showing a slight... 
Via Talk Markets
Topics Stocks
News headline image
2 Top Biotech Buyout Candidates ↗
Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be... 
Via Talk Markets
News headline image
3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition ↗
Discover these three biotech stocks set for major gains with groundbreaking health solutions. Invest in the future of medicine. 
Via InvestorPlace
News headline image
Tuesday Talk: Big-Tech Under Attack ↗
On Thursday the Justice Dept. filed an antitrust suit against Apple. The suit joins two others already filed against Google. How much this will affect the market in the long run is up for grabs. 
Via Talk Markets
News headline image
Biotechnology And Healthcare, A Bit Of A Lull ↗
Strong momentum of Tech and Chip stocks may be too good of a distraction for biotech investors. 
Via Talk Markets
News headline image
Healthcare And Biotech Update With Market At 2024 Highs ↗
The bull market is intact with technology Stocks dominating, but XLV is up 6.89%YTD. 
Via Talk Markets
News headline image
3 Biotech ETFs Overdue for a Bounce ↗
The biotech ETFs have been under serious pressure in recent years. Newfound momentum and looming lower rates could spark a comeback. 
Via InvestorPlace
Topics ETFs
News headline image
Millionaire Makers: 3 Sectors Poised for 20X Gains ↗
Dive into three explosive sectors that could yield 20X returns for the bold investor. Uncover these potential millionaire makers. 
Via InvestorPlace
News headline image
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits ↗
Given recent industry performance, the enthusiasm investors have for biotech stocks to buy is low. But these three companies seem promising. 
Via InvestorPlace
News headline image
3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024 ↗
Find out which under-the-radar biotech stocks have major catalysts on the horizon, and unlock their explosive growth potential. 
Via InvestorPlace
News headline image
Lottery Preference And Biotech Stocks: Trust The Financials, Not The Science ↗
Making a bet on biotech/pharma firms that have not yet achieved significant revenue is the equivalent of buying a lottery ticket—with the same poor risk/return relationship. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.